Press Release Distribution
immune response biopharma Press Releases+ XML/RSS
Immune Response BioPharma, Inc Announces the FDA has Accepted REMUNE HIV/AIDS Vaccine BLA for Review
By IMMUNE RESPONSE BIOPHARMA
Immune Response BioPharma, Inc., Today provides an update on REMUNE and announces the FDA has accepted the REMUNE HIV/AIDS vaccine BLA (biologics licensing application) for review for therapeutic treatment in adults with HIV/AIDS.
By IMMUNE RESPONSE BIOPHARMA INC
Immune Response BioPharma, Inc. Posts 2nd Half and Full Year 2014 Results Finishing the Year Strong with REMUNE HIV/AIDS Vaccine BLA FDA Filing
By Immune Response BioPharma, Inc.
Immune Response BioPharma, Inc. Publishes Phase III Full 806 Study Results, REMUNE Very Effective Demonstrating 0.7% HIV Progression vs 6% Estimated Rate & Subgroup Median Virologic Failure Delayed by 20 Weeks In REMUNE Group.
Page updated every 10 minutes